DEVELOPMENT AND CAUSES OF PROGERIA DISEASE

Authors

  • Muhammadova Mahfuza Muhammadova Kokand Universiteti Andijon filiali

Keywords:

Genetik kasallik, DNK mutatsiyasi, hujayra shikastlanishi, suyak deformatsiyasi

Abstract

Progeria is a rare genetic disease caused by a mutation in the LMNA gene. This mutation results in the production of the progerin protein, which disrupts the normal process of cell division and repair. As a result, the body begins to age prematurely. There is currently no complete cure for progeria. However, treatments such as farnesyltransferase inhibitor (FTI) drugs and gene therapy are important in slowing the progression of the disease.

References

Gordon, L. B., et al. (2016). Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. Circulation, 134(2), 114-125.

Merideth, M. A., et al. (2018). Phenotype and Course of Hutchinson-Gilford Progeria Syndrome. New England Journal of Medicine, 358(6), 592-604.

Ullrich, N. J., et al. (2019). Craniofacial Abnormalities in Hutchinson-Gilford Progeria Syndrome. American Journal of Medical Genetics Part A, 179(2), 177-182.

Burtner, C. R., & Kennedy, B. K. (2019). Progeria Syndromes and Aging: What is the Connection?. Clinical Genetics, 95(5), 457-466.

Olive, M., et al. (2020). Cardiovascular Pathology in Hutchinson-Gilford Progeria Syndrome. Journal of Medical Genetics, 57(7), 457-464.

Downloads

Published

2025-06-16

How to Cite

DEVELOPMENT AND CAUSES OF PROGERIA DISEASE. (2025). Universal International Scientific Journal, 2(4.5), 379-380. https://universaljurnal.uz/index.php/jurnal/article/view/2430